Your browser doesn't support javascript.
loading
Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: 6 years of follow-up.
Werneck, Gabriela; Rodrigues, Enda M R; Mantovani, Rafael M; Lane, Jovita S S; Silva, Ivani N.
Afiliación
  • Werneck G; Divisão de Endocrinologia Infantil e do Adolescente - Departamento de Pediatria, Faculdade de Medicina/Hospital das Clínicas, Universidade Federal de Minas Gerais, Av. Alfredo Balena 190, s/267, 30130-100, Belo Horizonte, MG,Brazil.
  • Rodrigues EMR; Faculdade de Medicina, Division of Pediatric Endocrinology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Mantovani RM; Faculdade de Medicina, Division of Pediatric Endocrinology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Lane JSS; Faculdade de Medicina/Hospital das Clínicas, Departamento de Radiologia e Imagem, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Silva IN; Faculdade de Medicina, Division of Pediatric Endocrinology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
J Pediatr Endocrinol Metab ; 32(5): 519-526, 2019 May 27.
Article en En | MEDLINE | ID: mdl-31075083
Background Testicular adrenal rest tumors (TARTs) leading to primary gonadal failure are the main etiology of infertility in congenital adrenal hyperplasia (CAH). We aimed at identifying the evolution of TART and related findings in young CAH patients. Methods Twelve male patients (3-23 years old) with 21-hydroxilase deficiency (11 with classic salt-wasting form) were included. Testicular ultrasonography (US) was performed in two moments, by a single blinded specialist in pediatric diagnostic imaging. Tumor progression was classified according to the Response Evaluation Criteria in Solid Tumors (RECIST). The clinical and laboratory data were retrieved from medical records. Serum 17-OH-progesterone (17OHP) and androstenedione concentrations were evaluated during the whole period of follow-up, from the CAH diagnosis. A logistic regression model with repeated measures was developed for the analysis. Results The prevalence of TART was 41.6% (n = 5) in the initial US evaluation and 66.6% (n = 8) after 6 years of follow-up. Tumor progression was detected in 4 of the 5 patients, and 1 presented with a stable tumor. Three patients presented with new tumors in the second evaluation. Most of the patients (n = 11) were pubertal, including a 7-year-old child with TART who presented with central precocious puberty. At regression analysis, it was observed that an inadequate hormonal control led to a 16 times greater chance of a patient to present with TART (OR = 16.08; confidence interval [CI] 95% = 2.38-108.81; p = 0.004). Conclusions We found a high prevalence of progressive TART in young pubertal subjects. US testicular screening should help in improving therapeutic optimization in CAH patients to reduce future impairment in fertility.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Hiperplasia Suprarrenal Congénita / Tumor de Resto Suprarrenal Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans / Male Idioma: En Revista: J Pediatr Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Hiperplasia Suprarrenal Congénita / Tumor de Resto Suprarrenal Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans / Male Idioma: En Revista: J Pediatr Endocrinol Metab Asunto de la revista: ENDOCRINOLOGIA / PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Alemania